$RLFTF VIP may be uniquely attractive to those focused on global countermeasures against COVID-19.
VIP may also be the only candidate in human trials that could be produced at a cost structure that is compatible with the needs of the developing world.”
(0)
(0)
Mondobiotech Holding AG Basel (RLFTF) Stock Research Links